Literature DB >> 20802948

Epidemiology of extended spectrum beta-lactamase producing Enterobacter bacteremia in a brazilian hospital.

Felipe Francisco Tuon1, Leila Carolina Bianchet, Sergio Ricardo Penteado-Filho.   

Abstract

INTRODUCTION: Enterobacter can be included in the group of extended spectrum beta-lactamases (EBSL)-producing bacteria, though few studies exist evaluating risk factors associated with this microorganism. A retrospective cohort study was conducted to determine risk factors associated with ESBL-producing-Enterobacter and mortality
METHODS: A retrospective cohort study with 58 bacteremia caused by ESBL-producing-Enterobacter (28 cases) and non-ESBL (30 cases)
RESULTS: Risk factors associated with ESBL-Enterobacter were trauma, length of hospitalization, admission to the intensive care unit, urinary catheter and elective surgery (p< 0.05). The survival curves were similar for ESBL and non-ESBL
CONCLUSIONS: ESBL-producing-Enterobacter bacteremia is prevalent and the survival curve was similar to non-ESBL-producing strains.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20802948     DOI: 10.1590/s0037-86822010000400022

Source DB:  PubMed          Journal:  Rev Soc Bras Med Trop        ISSN: 0037-8682            Impact factor:   1.581


  4 in total

Review 1.  Piperacillin-tazobactam as alternative to carbapenems for ICU patients.

Authors:  Benoit Pilmis; Vincent Jullien; Alexis Tabah; Jean-Ralph Zahar; Christian Brun-Buisson
Journal:  Ann Intensive Care       Date:  2017-11-10       Impact factor: 6.925

2.  Is nosocomial Escherichia coli bacteremia a predictive risk factor for mortality?

Authors:  Felipe F Tuon; Jaime L Rocha; Fernanda A Guadagnin; Márcia S Alves
Journal:  Braz J Infect Dis       Date:  2013-09-20       Impact factor: 3.257

3.  KPC-producing Enterobacter aerogenes infection.

Authors:  Felipe F Tuon; Camila Scharf; Jaime L Rocha; Juliette Cieslinsk; Guilherme Nardi Becker; Lavinia N Arend
Journal:  Braz J Infect Dis       Date:  2015-02-23       Impact factor: 3.257

4.  A simple mathematical model to determine the ideal empirical antibiotic therapy for bacteremic patients.

Authors:  Felipe F Tuon; Jaime L Rocha; Talita M Leite; Camila Dias
Journal:  Braz J Infect Dis       Date:  2014-03-01       Impact factor: 3.257

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.